HALLIE CARTER: Open Payments
NPI 1770103053 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 65 payments from 10 companies in 2025. Trend: 2023 $619 · 2024 $500 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $453 |
| ABBVIE INC. | 19 | $156 |
| Supernus Pharmaceuticals, Inc. | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, Qelbree, FANAPT, REXULTI, COBENFY, Auvelity, SPRAVATO.
Industry payments across MS — which companies pay providers there.
